| |
|
Drug Related Products News
|
NBTY Gains on Strong Q3 Sales
Fri 1:51 pm ET (Zacks.com)
NBTY reported better-than-expected preliminary fiscal third-quarter results, sending its shares higher by nearly 4% so far today.
|
| | |
Locate Industry by Company
|
| Market Capitalization: | 9B | | Price
/ Earnings: | 31.4 | | Price
/ Book: | 7.4 | | Net
Profit Margin (mrq): | 2.8% | | Price
To Free Cash Flow (mrq): | 219.5 | | Return
on Equity: | 7.1% | | Total
Debt / Equity: | 0.0 | | Dividend
Yield: | 1.1% |
|